The University of Chicago Header Logo

Connection

Ann M. Zmuda to Humans

Back to Details
This is a "connection" page, showing publications Ann M. Zmuda has written about Humans.
Ann M. Zmuda
Connection Strength
0.026
Humans
  1. Assessment of the effects of a multi-component, individualized physiotherapy program in patients receiving hospice services in the home. BMC Palliat Care. 2020 Jul 09; 19(1):101.
    View in: PubMed
    Score: 0.006
  2. TIME CDST: an updated tool to address the current challenges in wound care. J Wound Care. 2019 03 03; 28(3):154-161.
    View in: PubMed
    Score: 0.006
  3. A treatment algorithm for neuropathic (Charcot) midfoot deformity. Foot Ankle. 1993 May; 14(4):189-97.
    View in: PubMed
    Score: 0.004
  4. Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation. Thromb Haemost. 1984 Apr 30; 51(2):186-8.
    View in: PubMed
    Score: 0.002
  5. Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol. 1976 Jul; 58(1 PT 1):10-8.
    View in: PubMed
    Score: 0.001
  6. [Hydroxyproline in serum and urine in children with pulmonary hypertension in the course of congenital heart defects]. Przegl Lek. 1994; 51(10):431-6.
    View in: PubMed
    Score: 0.001
  7. Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int J Tissue React. 1993; 15(2):55-64.
    View in: PubMed
    Score: 0.001
  8. Influence of no-donor (SIN-1) on functions of inflammatory cells. Agents Actions. 1991 Jan; 32(1-2):37-40.
    View in: PubMed
    Score: 0.001
  9. [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. Fortschr Med. 1989 Jul 10; 107(20):450-2.
    View in: PubMed
    Score: 0.001
  10. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension]. Kardiol Pol. 1988; 31(10):626-32.
    View in: PubMed
    Score: 0.001
  11. [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs]. Pol Tyg Lek. 1987 Dec 21-28; 42(51-52):1643-8.
    View in: PubMed
    Score: 0.001
  12. Plasma antioxidant potency and serum copper levels in atherosclerosis. Pol J Pharmacol Pharm. 1985 Mar-Apr; 37(2):123-32.
    View in: PubMed
    Score: 0.001
  13. The use of carprofen, a non-steroidal antiinflammatory agent, in peptic ulcer diseases. Hepatogastroenterology. 1983 Dec; 30(6):261-5.
    View in: PubMed
    Score: 0.000
  14. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins. 1981 Nov; 22(5):795-807.
    View in: PubMed
    Score: 0.000
  15. Increased platelet activity after termination of prostacyclin infusion into man. Prostaglandins. 1981 May; 21(5):827-32.
    View in: PubMed
    Score: 0.000
  16. Prostacyclin and blood glucose levels in humans and rabbits. Prostaglandins. 1981 Jan; 21(1):113-21.
    View in: PubMed
    Score: 0.000
  17. A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets. Pharmacol Res Commun. 1977 Feb; 9(2):109-16.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.